AAAAAA

   
Results: 1-25 | 26-35 |
Results: 26-35/35

Authors: Schols, D Proost, P Struyf, S Wuyts, A De Meester, I Scharpe, S Van Damme, J De Clercq, E
Citation: D. Schols et al., CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity (vol 39, pg 175, 1998), ANTIVIR RES, 40(3), 1999, pp. 189-190

Authors: Song, C Kenis, G van Gastel, A Bosmans, E Lin, AH de Jong, R Neels, H Scharpe, S Janca, A Yasukawa, K Maes, M
Citation: C. Song et al., Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes, PSYCHIAT R, 85(3), 1999, pp. 293-303

Authors: Maes, M Lin, AH Bonaccorso, S Goossens, F Van Gastel, A Pioli, R Delmeire, L Scharpe, S
Citation: M. Maes et al., Higher serum prolyl endopeptidase activity in patients with post-traumaticstress disorder, J AFFECT D, 53(1), 1999, pp. 27-34

Authors: Korom, S De Meester, I Schmidbauer, G Pratschke, J Brendel, MD Durinx, C Schwemmle, K Haemers, A Scharpe, S Kupiec-Weglinski, JW
Citation: S. Korom et al., Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: Effects on humoral immunity, TRANSPLAN P, 31(1-2), 1999, pp. 778-778

Authors: Korom, S De Meester, I Coito, AJ Graser, E Pratschke, J Konig, S Grimm, H Volk, HD Scharpe, S Kupiec-Weglinski, JW
Citation: S. Korom et al., CD26/DPP IV-mediated modulation of acute rejection, TRANSPLAN P, 31(1-2), 1999, pp. 873-873

Authors: Maes, M DeVos, N Wauters, A Demedts, P Maurits, V Neels, H Bosmans, E Altamura, C Lin, A Song, C Vandenbroucke, M Scharpe, S
Citation: M. Maes et al., Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease, J PSYCH RES, 33(5), 1999, pp. 397-405

Authors: Belyaev, A Zhang, XM Augustyns, K Lambeir, AM De Meester, I Vedernikova, I Scharpe, S Haemers, A
Citation: A. Belyaev et al., Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors, J MED CHEM, 42(6), 1999, pp. 1041-1052

Authors: Struyf, S Proost, P Schols, D De Clercq, E Opdenakker, G Lenaerts, JP Detheux, M Parmentier, M De Meester, I Scharpe, S Van Damme, J
Citation: S. Struyf et al., CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3, J IMMUNOL, 162(8), 1999, pp. 4903-4909

Authors: Proost, P Struyf, S Schols, D Opdenakker, G Sozzani, S Allavena, P Mantovani, A Augustyns, K Bal, G Haemers, A Lambeir, AM Scharpe, S Van Damme, J De Meester, I
Citation: P. Proost et al., Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IVbeyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction, J BIOL CHEM, 274(7), 1999, pp. 3988-3993

Authors: Song, C Lin, AH De Jong, R Vandoolaeghe, E Kenis, G Bosmans, E Whelan, A Scharpe, S Maes, M
Citation: C. Song et al., Cytokines in detoxified patients with chronic alcoholism without liver disease: Increased monocytic cytokine production, BIOL PSYCHI, 45(9), 1999, pp. 1212-1216
Risultati: 1-25 | 26-35 |